Literature DB >> 25756146

Systematic review of clinical features of suspected prostate cancer in primary care.

Sheila-Mae Young, Praveen Bansal, Emily T Vella, Antonio Finelli, Cheryl Levitt, Andrew Loblaw.   

Abstract

OBJECTIVE: To systematically review the literature and provide an update and integration of existing peer-reviewed guidelines with recent systematic reviews and with primary studies related to the early recognition and management of prostate cancer in primary care. DATA SOURCES: We searched MEDLINE and EMBASE for relevant articles. The quality of the evidence to support existing guideline recommendations and the consistency of recommendations with updated evidence were assessed. Applicability in a Canadian primary care setting was also evaluated. STUDY SELECTION: All studies conducted in the primary care setting that provided information on clinical features predictive of prostate cancer were included. Also, studies that assessed the accuracy of nomograms to predict prostate cancer were reviewed. SYNTHESIS: The findings suggest that lower urinary tract symptoms are not highly predictive of prostate cancer. However, evidence suggests that FPs might be good at discriminating between patients with and without prostate cancer using digital rectal examination and prostate-specific antigen testing. Nomograms might also be useful in assessing patients for aggressive prostate cancers.
CONCLUSION: The results of this review can be used to inform recommendations for referral for suspected prostate cancer in the primary care setting. They could also inform development of prostate cancer diagnostic assessment programs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25756146      PMCID: PMC4301783     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  24 in total

1.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

2.  Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers.

Authors:  Sheila-Mae Young; Praveen Bansal; Emily T Vella; Antonio Finelli; Cheryl Levitt; Andrew Loblaw
Journal:  Can Fam Physician       Date:  2015-01       Impact factor: 3.275

3.  Risk of prostate cancer associated with benign prostate disease: a primary care case-control study.

Authors:  Brian S Buckley; Marie Carmela M Lapitan; Colin R Simpson; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2011-11       Impact factor: 5.386

4.  Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Authors:  Robert K Nam; Michael W Kattan; Joseph L Chin; John Trachtenberg; Rajiv Singal; Ricardo Rendon; Laurence H Klotz; Linda Sugar; Christopher Sherman; Jonathan Izawa; David Bell; Aleksandra Stanimirovic; Vasundara Venkateswaran; Eleftherios P Diamandis; Changhong Yu; D Andrew Loblaw; Steven A Narod
Journal:  J Clin Oncol       Date:  2011-06-20       Impact factor: 44.544

5.  Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.

Authors:  J R Fowler JE; S A Bigler; P B Farabaugh; S S Wilson
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

6.  Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.

Authors:  Satoru Kawakami; Noboru Numao; Yuhei Okubo; Fumitaka Koga; Shinya Yamamoto; Kazutaka Saito; Yasuhisa Fujii; Junji Yonese; Hitoshi Masuda; Kazunori Kihara; Iwao Fukui
Journal:  Eur Urol       Date:  2008-01-15       Impact factor: 20.096

7.  The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.

Authors:  Amr M Hawary; Hazel E Warburton; Richard J Brough; Gerald N Collins; Stephen C Brown; Patrick H O'Reilly; Adebanji Ab Adeyoju
Journal:  Ann R Coll Surg Engl       Date:  2008-09       Impact factor: 1.891

8.  An audit of urology two-week wait referrals in a large teaching hospital in England.

Authors:  Anup Mathew; K M Desai
Journal:  Ann R Coll Surg Engl       Date:  2009-04-02       Impact factor: 1.891

9.  Screening by lower urinary tract symptoms vs asymptomatic prostate-specific antigen levels leading to radical prostatectomy in Danish men: tumour characteristics and treatment outcome.

Authors:  Michael Borre
Journal:  BJU Int       Date:  2009-01-12       Impact factor: 5.588

10.  Risk profiles of prostate cancers identified from UK primary care using national referral guidelines.

Authors:  H Serag; S Banerjee; K Saeb-Parsy; S Irving; K Wright; S Stearn; A Doble; V J Gnanapragasam
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

View more
  4 in total

1.  Guideline for referral of patients with suspected prostate cancer by family physicians and other primary care providers.

Authors:  Sheila-Mae Young; Praveen Bansal; Emily T Vella; Antonio Finelli; Cheryl Levitt; Andrew Loblaw
Journal:  Can Fam Physician       Date:  2015-01       Impact factor: 3.275

2.  Men's perception of information and descriptions of emotional strain in the diagnostic phase of prostate cancer-a qualitative individual interview study.

Authors:  Maja Elisabeth Juul Søndergaard; Kirsten Lode; Svein Reidar Kjosavik; Sissel Eikeland Husebø
Journal:  Scand J Prim Health Care       Date:  2021-11-21       Impact factor: 2.581

3.  Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients.

Authors:  Samuel W D Merriel; Lucy Pocock; Emma Gilbert; Sam Creavin; Fiona M Walter; Anne Spencer; Willie Hamilton
Journal:  BMC Med       Date:  2022-02-07       Impact factor: 8.775

4.  Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.

Authors:  Pia Kirkegaard; Adrian Edwards; Trine Laura Overgaard Nielsen; Torben Falck Ørntoft; Karina Dalsgaard Sørensen; Michael Borre; Flemming Bro
Journal:  BMC Fam Pract       Date:  2018-02-17       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.